(NASDAQ: OPK) Opko Health's forecast annual revenue growth rate of 4.19% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.11%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.39%.
Opko Health's revenue in 2025 is $689,408,000.On average, 5 Wall Street analysts forecast OPK's revenue for 2025 to be $516,922,919,735, with the lowest OPK revenue forecast at $488,837,747,769, and the highest OPK revenue forecast at $539,831,043,002. On average, 5 Wall Street analysts forecast OPK's revenue for 2026 to be $544,430,749,260, with the lowest OPK revenue forecast at $486,934,421,042, and the highest OPK revenue forecast at $610,174,826,628.
In 2027, OPK is forecast to generate $633,968,789,877 in revenue, with the lowest revenue forecast at $618,113,285,186 and the highest revenue forecast at $663,388,669,710.